IPOs and Secondaries
IPOs and Secondaries Articles
More than 6 million CytomX shares are expected to price in the range of $14 to $16 in an IPO valued up to more than $122 million.
Published:
Digital Turbine has announced the pricing of its public offering of 7.6 million shares of common stock to the public.
Published:
Some 2.6 million Allegiance Bancshares shares are expected to price within the range of $22 to $24 in an IPO valued up to more than $71 million.
Published:
Consumer electronics company Vizio has chosen to list on the Nasdaq Global Select Market under the symbol VZIO.
Published:
Last Updated:
By Matthew Bowden www.digitallyrefreshing.com, via Wikimedia CommonsAquaVenture Holdings LLC filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public...
Published:
Last Updated:
24/7 Wall St. has screened the list of companies that the quantitative strategies team at Jefferies puts out for the high-profile stocks that will be making their Russell index debuts.
Published:
ThinkstockLast week was not a standout for initial public offerings (IPOs). There were three on the calendar, and only a blank-check company was able successfully to launch in the public markets. Two...
Published:
Last Updated:
ThinkstockPetco Holdings, Inc. filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering. There were no terms given in the filing. The...
Published:
Last Updated:
1st Century Bancshares has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Published:
Aclaris Therapeutics intends to offer 5 million shares in its IPO valued at up to $92 million.
Published:
Albertsons Companies has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Published:
Pure Storage expects to price 25 million shares within the range of $16 to $18, for an initial public offering valued up to $517.5 million.
Published:
SiteOne Landscape Supply has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Published:
Bioceres has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Published:
Intra-Cellular Therapies is gearing up for its secondary offering, and in preparation it just set the price.
Published: